Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Preoperative Recommendations Engine, 77107 [2013-30359]

Download as PDF Federal Register / Vol. 78, No. 245 / Friday, December 20, 2013 / Notices Points of Contact for Further Information or Inquiries: For further information and inquires, or to request a meeting with the DOD Compliance Officer or his Government Compliance Team, interested parties should contact either Mrs. Sarah Beth Cliatt (Compliance Division Chief), Tel: 719– 556–2042; or Colonel Marc Berkstresser (Deputy Compliance Division Chief), Tel: 703–614–7842. Henry Williams, Acting Air Force Federal Register Liaison Officer. BILLING CODE 5001–10–P DEPARTMENT OF DEFENSE Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Preoperative Recommendations Engine Department of the Army, DoD. Notice. AGENCY: Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/ 849,910, entitled ‘‘Preoperative Recommendations Engine,’’ filed on January 14, 2013. The United States Government, as represented by the Secretary of the Army, has rights to this invention. ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR–JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702– 5012. SUMMARY: For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619–7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Applications (ORTA), (301) 619–6664, both at telefax (301) 619–5034. SUPPLEMENTARY INFORMATION: The invention relates to a system that compiles patient-specific, evidencedbased perioperative recommendations for the consulting surgical specialist, and creates medication management instructions directly for the patients use. Its modular architecture is easily maintained and updated, assuring currency with cutting-edge perioperative practices. Its adoption facilitates the implementation of accepted best practices, potentially emcdonald on DSK4SPTVN1PROD with NOTICES FOR FURTHER INFORMATION CONTACT: 16:44 Dec 19, 2013 [FR Doc. 2013–30359 Filed 12–19–13; 8:45 am] BILLING CODE 3710–08–P DEPARTMENT OF DEFENSE Department of the Army AGENCY: Department of the Army VerDate Mar<15>2010 Brenda S. Bowen, Army Federal Register Liaison Officer. Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Antibody-Dependent Cellular Cytoxicity (ADCC)-Mediating Antibodies [FR Doc. 2013–30224 Filed 12–19–13; 8:45 am] ACTION: minimizing perioperative risk and optimizing surgical outcomes. Jkt 232001 ACTION: Department of the Army, DoD. Notice. Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/ 762,543, entitled ‘‘Antibody-Dependent Cellular Cytoxicity (ADCC)-Mediating Antibodies,’’ filed on February 8, 2013. The United States Government, as represented by the Secretary of the Army, has rights to this invention. SUMMARY: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR–JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702– 5012. ADDRESSES: For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619–7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Applications (ORTA), (301) 619–6664, both at telefax (301) 619–5034. FOR FURTHER INFORMATION CONTACT: The invention relates to AntibodyDependent cellular cytoxicity (ADCC)mediating antibodies, and, in particular, to ADCC-mediating antibodies (and fragments thereof) suitable for use, for example, in reducing the risk of HIV–1 infection in a subject. The invention further relates to compositions comprising such antibodies or antibody fragments. SUPPLEMENTARY INFORMATION: Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. 2013–30367 Filed 12–19–13; 8:45 am] DEPARTMENT OF DEFENSE Department of the Army Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Therapeutic Peptides That Inhibit Rift Valley Fever Virus, Ebola Virus, Andes Virus and Vesicular Stomatitis Virus Infectivity, Compositions and Methods AGENCY: ACTION: Department of the Army, DoD. Notice. Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/733,966, entitled ‘‘Therapeutic Peptides that Inhibit Rift Valley Fever Virus, Ebola Virus, Andes Virus and Vesicular Stomatitis Virus Infectivity, Compositions and Methods,’’ filed on December 6, 2012. The United States Government, as represented by the Secretary of the Army, has rights to this invention. SUMMARY: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR–JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702– 5012. ADDRESSES: For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619–7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Applications (ORTA), (301) 619–6664, both at telefax (301) 619–5034. FOR FURTHER INFORMATION CONTACT: The invention relates to novel, broad spectrum, antiviral peptides, compositions containing one or more of these and their use for the prophylactic treatment against and/or therapeutic treatment of infection by hemorrhagic fever viruses (HFVs), such as Rift Valley fever virus (RVFV), Ebola virus (EBOV), and Andes virus (ANDV). Additionally, these peptides were capable of inhibiting vesticular stomatitis virus (VSV), and agricultural pathogen with limited therapeutic availability. SUPPLEMENTARY INFORMATION: Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. 2013–30357 Filed 12–19–13; 8:45 am] BILLING CODE 3710–08–P BILLING CODE 3710–08–P PO 00000 Frm 00014 Fmt 4703 Sfmt 9990 77107 E:\FR\FM\20DEN1.SGM 20DEN1

Agencies

[Federal Register Volume 78, Number 245 (Friday, December 20, 2013)]
[Notices]
[Page 77107]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-30359]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Notice of Availability for Exclusive, Non-Exclusive, or 
Partially-Exclusive Licensing of an Invention Concerning Preoperative 
Recommendations Engine

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Announcement is made of the availability for licensing of the 
invention set forth in U.S. Provisional Patent Application Serial No. 
61/849,910, entitled ``Preoperative Recommendations Engine,'' filed on 
January 14, 2013. The United States Government, as represented by the 
Secretary of the Army, has rights to this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research and Technology Applications (ORTA), (301) 619-
6664, both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The invention relates to a system that 
compiles patient-specific, evidenced-based perioperative 
recommendations for the consulting surgical specialist, and creates 
medication management instructions directly for the patients use. Its 
modular architecture is easily maintained and updated, assuring 
currency with cutting-edge perioperative practices. Its adoption 
facilitates the implementation of accepted best practices, potentially 
minimizing perioperative risk and optimizing surgical outcomes.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2013-30359 Filed 12-19-13; 8:45 am]
BILLING CODE 3710-08-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.